VIGILARE WEALTH MANAGEMENT Adaptimmune Therapeutics plc Transaction History

VIGILARE WEALTH MANAGEMENT portfolio value:

$40,000
portfolio value

VIGILARE WEALTH MANAGEMENT quarter portfolio value change:

-36.76%
quarter

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -11.96% -5K shares -31K $1.08 36.8K
Q2 2022 share Increase 0.00% 41.8K shares 71K $1.7 41.8K
Q1 2022 share Decrease -100.00% -98.45K shares -369K $2.06 0
Q4 2021 share Decrease -1.50% -1.5K shares -148K $3.87 98.45K
Q3 2021 share Increase +84.24% 45.7K shares 286K $5.17 99.95K
Q2 2021 share Increase +45.05% 16.85K shares 32K $4.26 54.25K
Q1 2021 share Increase +113.71% 19.9K shares 105K $5.31 37.4K
Q4 2020 share Increase 0.00% 17.5K shares 94K $5.39 17.5K